Assessment Of COPD Severity In A Real-Life Cohort Of German Patients-1-Year Follow-Up Data From The Daccord Study

被引:0
|
作者
Worth, H. [1 ]
Buhl, R. [2 ]
Criee, C. -P. [3 ]
Kardos, P. [4 ,5 ]
Lossi, N. [6 ]
Mailaender, C. [6 ]
Vogelmeier, C. [7 ]
机构
[1] Facharztforum Fuerth, Furth, Germany
[2] Univ Hosp Mainz, Mainz, Germany
[3] Evangel Hosp Goettingen Weende, Bovenden, Germany
[4] Grp Practice, Frankfurt, Germany
[5] Ctr Allergy Resp & Sleep Med, Frankfurt, Germany
[6] Novartis Pharma GmbH, Nurnberg, Germany
[7] Univ Marburg, Marburg, Germany
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1706
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
    De Greef, Axel
    Thirion, Romane
    Ghislain, Pierre-Dominique
    Baeck, Marie
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2869 - 2877
  • [22] Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
    De Greef, Axel
    Thirion, Romane
    Ghislain, Pierre-Dominique
    Baeck, Marie
    DERMATOLOGY AND THERAPY, 2023, : 2869 - 2877
  • [23] Direct cost analysis of COPD patients: A 1 year follow-up study
    Akel, Unal
    Hacievliyagil, Suleyman Savas
    Aytemur, Zeynep Ayfer
    Yologlu, Saim
    Kaya, Saltuk Bugra
    Akel, Nazan
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [24] A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study
    Kardos, Peter
    Vogelmeier, Claus
    Worth, Heinrich
    Buhl, Roland
    Lossi, Nadine S.
    Mailaender, Claudia
    Criee, Carl-Peter
    RESPIRATORY MEDICINE, 2017, 124 : 57 - 64
  • [25] Psychological predictors of real-life experience with Erenumab in chronic migraine with or without medication overuse: data from a 1-year follow-up
    Bottiroli, S.
    Deicco, R.
    Vaghi, G.
    Fiammingo, G.
    Guaschino, E.
    Allena, M.
    Ghiotto, N.
    Tassorelli, C.
    Sances, G.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 92 - 92
  • [26] PREDICTORS OF COPD MORTALITY, 2 YEAR FOLLOW-UP DATA FROM THE ARCADE STUDY
    Gale, N. S.
    Albarrati, A.
    Munnery, M. M.
    Tal-Singer, R.
    Cockcroft, J. R.
    Shale, D. J.
    THORAX, 2015, 70 : A84 - A84
  • [27] Psychological predictors of real-life experience with Erenumab in chronic migraine with or without medication overuse: data from a 1-year follow-up
    Bottiroli, S.
    Deicco, R.
    Vaghi, G.
    Fiammingo, G.
    Guaschino, E.
    Allena, M.
    Ghiotto, N.
    Tassorelli, C.
    Sances, G.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 61 - 61
  • [28] Real-Life Follow-up in Cows Milk Immunotherapy: Clinical and Serological Data
    Poza-Guedes, Paloma
    Gonzalez-Perez, Ruperto
    Sanchez-Machin, Inmaculada
    Matheu, Victor
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB130 - AB130
  • [29] COPD management in general practice - one year follow-up of the Swiss COPD cohort study
    Jochmann, A.
    Miedinger, D.
    Toeroek, S. Schafroth
    Scherr, A.
    Tamm, M.
    Leuppi, J. D.
    SWISS MEDICAL WEEKLY, 2010, 140 (13-14) : 7S - 7S
  • [30] Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situation
    Chartier, F.
    Rouillon, F.
    Berggren, L.
    Jamonneau, I.
    Falissard, B.
    Llorca, P. M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (04): : 303 - 310